Oncology drug manufacturing in India is shaping the future of global cancer treatment. With rising cancer cases worldwide, the demand for effective and affordable oncology medicines is increasing rapidly. India has emerged as a trusted hub for oncology drug development, …
With the expansion of the global oncology market, there is increasing demand for precision due to rising cancer incidence and the rapid adoption of targeted therapies, biologics, and complex injectables. This is necessary because pharmaceutical companies are always under immense …
The pharmaceutical sector stands at the intersection of science, safety, and standards. Every new drug, treatment, or medical innovation must pass through a rigorous web of pharmaceutical regulations and compliance before launch. These frameworks are no longer formalities—they safeguard public …
Pinnacle Life Science is committed to delivering high-quality, innovative medicines across 90+ countries. With US FDA-approved facilities and advanced R&D capabilities, the company is driving global health impact through cutting-edge technologies—including artificial intelligence (AI) and machine learning (ML). …
The healthcare sector is undergoing a massive transformation, driven by digital advancements. Whether in hospitals or pharmaceutical companies, digital tools are redefining diagnosis, monitoring, and treatment. Among these innovations, Remote Patient Monitoring (RPM) stands out as a game changer-bridging the …
The transformation and structural shift in CDMOs has reached its climax. It’s all because the rising demand for complex biologics—especially in the Oncology Pharma sector includes sponsor preferences and persistent supply-chain pressures. This has all pushed CDMOs to rethink their …